Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury-Reference-Cited by-同舟云学术

Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury

Published:2018-05-14 Issue:1 Volume:15 Page:
ISSN:1742-2094
Container-title:Journal of Neuroinflammation
language:en
Short-container-title:J Neuroinflammation

Author:

Piro Justin R.,Suidan Georgette L.,Quan Jie,Pi YeQing,O’Neill Sharon M.,Ilardi Marissa,Pozdnyakov Nikolay,Lanz Thomas A.,Xi Hualin,Bell Robert D.,Samad Tarek A.

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1186/s12974-018-1166-9.pdf

Reference52 articles.

1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13–25.

2. Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the blood-brain barrier. Cell. 2015;163(5):1064–78.

3. Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA, Shah GN, Price TO, Fleegal-Demotta MA, Butterfield DA, et al. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer’s disease. Brain Behav Immun. 2009;23(4):507–17.

4. Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1–12.

5. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010;87(5):779–89.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aquaporin 4 and the endocannabinoid system: a potential therapeutic target in brain injury;Experimental Brain Research;2024-07-23

2. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis;Neuropharmacology;2024-07

3. Toll-like receptor signalling as a cannabinoid target;Biochemical Pharmacology;2024-04

4. Host peripheral immune dynamics increase HIV-associated neurocognitive disorders incidence and progression;HIV-Associated Neurocognitive Disorders;2024

5. Blood-spinal cord barrier disruption in degenerative cervical myelopathy;Fluids and Barriers of the CNS;2023-09-25